恩夫韦肽（CAS 159519-65-0）：分子式 C204H301N51O64、分子量 4492。
| CAS号 | 159519-65-0 |
|---|---|
| 分子式 | C204H301N51O64 |
| 分子量 | 4492 |
| LogP | -14.7 |
| 应用领域 | Uses: Medication、Antiviral (systemic)、Methods of Manufacturing: Preparation ... D.P. Bolognesi et al、WO 94 28920、eidem、US 5464933 (1994、1995 both to Duke University)、Formulations、Preparations: Parenteral: For injection: 108 mg Fuzeon (with sterile water for injection diluent)、(Roche).、General Manufacturing Information: Whilte data specific to enfuvirtide were not located(SRC、2005)、the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2). Studies have indicated that several polar pharmaceutically active compounds can leach through subsoils into aquifers(1). |
登记用途：Uses: Medication、Antiviral (systemic)、Methods of Manufacturing: Preparation ... D.P. Bolognesi et al、WO 94 28920、eidem、US 5464933 (1994、1995 both to Duke University)、Formulations、Preparations: Parenteral: For injection: 108 mg Fuzeon (with sterile water for injection diluent)、(Roche).、General Manufacturing Information: Whilte data specific to enfuvirtide were not located(SRC、2005)、the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2). Studies have indicated that several polar pharmaceutically active compounds can leach through subsoils into aquifers(1).。
恩夫韦肽 是一种化工化合物，登记 CAS 号为 159519-65-0，分子式 C204H301N51O64（分子量 4492）。
登记 CAS 号：159519-65-0
其分子式 C204H301N51O64 由 204 个碳、301 个氢、51 个氮、64 个氧 组成。
别名/同义词：恩夫韦肽 · Enfuvirtide
恩夫韦肽 的 CAS 登记号为 159519-65-0。
分子式 C204H301N51O64，分子量 4492。
别名/同义词：恩夫韦肽、Enfuvirtide。
登记用途：Uses: Medication、Antiviral (systemic)、Methods of Manufacturing: Preparation ... D.P. Bolognesi et al、WO 94 28920、eidem、US 5464933 (1994、1995 both to Duke University)、Formulations、Preparations: Parenteral: For injection: 108 mg Fuzeon (with sterile water for injection diluent)、(Roche).、General Manufacturing Information: Whilte data specific to enfuvirtide were not located(SRC、2005)、the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are therefore discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2). Studies have indicated that several polar pharmaceutically active compounds can leach through subsoils into aquifers(1).。
恩夫韦肽（CAS 159519-65-0）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 159519-65-0 |
|---|---|
| PubChem CID | 16130199 |
| Molecular formula | C204H301N51O64 |
| UNII (FDA) | 19OWO1T3ZE |
| Molecular Weight | 4492 |
|---|---|
| XLogP3 | -14.7 |
| Hydrogen Bond Donor Count | 63 |
| Hydrogen Bond Acceptor Count | 67 |
| Rotatable Bond Count | 151 |
| Exact Mass | 4491.1933541 |
| Monoisotopic Mass | 4489.1866445 |
| Topological Polar Surface Area | 1900 |
| Heavy Atom Count | 319 |
| Hydrophobicity | -0.875 |
|---|
Enfuvirtide; Pentafuside; Fuzeon; DP178; DP-178; Enfuvirtida; CHEBI:608828; Fuzeon T-20; 19OWO1T3ZE; DTXSID20166672; peptide T20; T20, Peptide; enfuvirtidum; RefChem:55093; DTXCID8089163; J05AX07
| Reported hazard statements | H317 (100%) |
|---|
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, and P501 (click each P-code to see the statement)
Enfuvirtide · CAS 159519-65-0 · C204H301N51O64. UNII 19OWO1T3ZE. Hydrophobicity: -0.875.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Enfuvirtide